107
Views
16
CrossRef citations to date
0
Altmetric
Review

Emerging options in growth hormone therapy: an update

&
Pages 411-419 | Published online: 30 Aug 2011

References

  • RabenMSTreatment of a pituitary dwarf with human growth hormoneJ Clin Endocrinol Metab195818890190313563618
  • FrasierSDThe not-so-good old days: working with pituitary growth hormone in North America, 1956–1985J Pediatr19971311 Pt 2S149255217
  • HintzRLThe prismatic case of Creutzfeldt-Jacob disease associated with primary growth hormone treatmentJ Clin Endocrinol Metab1995808229823017629222
  • GoeddelDVHeynekerHLHozumiTDirect expression in Escherichia coli of a DNA sequence coding for human growth hormoneNature19792815732544548386136
  • FlodhHHuman growth hormone produced with recombinant DNA technology: development and productionActa Paediatr Scand Suppl1986325193296632
  • MassaGGVanderschueren-LodeweyckxMBouillonRFive-year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormoneClin Endocrinol (Oxf)19933821371428435894
  • FranklinSLGeffnerMEGrowth hormone: the expansion of available products and indicationsEndocrinol Metab Clin North Am200938358761119717006
  • WilsonDMBakerBHintzRLRosenfeldRGSubcutaneous versus intramuscular growth hormone therapy: growth and acute somatomedin responsePediatrics19857633613644034296
  • MilnerRDRussell-FraserTBrookCGExperience with human growth hormone in Great Britain: the report of the MRC Working PartyClin Endocrinol (Oxf)19791111538229995
  • Albertsson-WiklandKWestphalOWestgrenUDaily subcutaneous administration of human growth hormone in growth hormone deficient childrenActa Paediatr Scand198675189973513479
  • JorgensenJOMollerNLaruritzenTAlbertiKGOrskovHChristiansenJSEvening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolitesJ Clin Endocrinol Metab19907012072142294131
  • KastrupKWChristiansenJSAndersenJKOrskovHIncreased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient childrenActa Endocrinol (Copenh)198310421481526637329
  • MacGillivrayMHBaptistaJJohansonAOutcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study GroupJ Clin Endocrinol Metab1996815180618098626839
  • BlethenSLBaptistaJKuntzieJFoleyTLaFranchiSJohansonAAdult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study GroupJ Clin Endocrinol Metab19978224184209024229
  • FrindikJPBaptistaJAdult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth studyPediatrics19991044 Pt 21000100410506251
  • MaghnieMAmbrosiniLCappaMAdult heights in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficienciesJ Clin Endocrinol Metab20069182900290516684828
  • RichmondEJRogolADCurrent indications for growth hormone therapy for children and adolescentsHindmarshPCCurrent Indications for Growth Hormone Therapy182nd edBaselKarger201092108
  • HintzRLCurrent and potential therapeutic uses of growth hormone and insulin-like growth factor IEndocrinol Metab Clin North Am19962537597738879998
  • RaoEWeissBFukamiMPseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndromeNat Genet199716154639140395
  • OgataTSHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosisGrowth Horm IGF Res19999Suppl B535710549307
  • BinderGSchwarzeCPRankeMBIdentification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormoneJ Clin Endocrinol Metab200085124524910634394
  • KofoedEMHwaVLittleBGrowth hormone insensitivity associated with a STAT5b mutationN Engl J Med2003349121139114713679528
  • DomeneHMBengoleaSVMartinezASDeficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunitN Engl J Med2004350657057714762184
  • SalernoMBalestrieriBMatrecanoEAbnormal GH receptor signalling in children with idiopathic short statureJ Clin Endocrinol Metab20018683882388811502828
  • SavageMOCamacho-HübnerCDavidAIdiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?Eur J Endocrinol2007157Suppl 1S333717785695
  • RosenfeldRGThe molecular basis of idiopathic short statureGrowth Horm IGF Res200515Suppl AS3516023877
  • KempSFKuntzieJAttieKMEfficacy and safety results of long-term growth hormone treatment of idiopathic short statureJ Clin Endocrinol Metab20059095247525315998780
  • KempSFDanaKFraneJLippeBIdiopathic Short Stature (ISS): What has changed since FDA approval of growth hormone (GH) for this diagnosis?Data from the Genentech (GNE) National Cooperative Growth Study (NCGS)Paper presented at the Annual Meeting of The Endocrine SocietyJune 2–3, 2007Toronto, Canada
  • RossJLKowalKQuigleyCAThe phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri–Weill dyschondrosteosis and Turner SyndromeJ Pediatr2005147449950716227037
  • BangPBjerknesRDahlgrenJA comparison of different definitions of growth response in short prepubertal children treated with growth hormoneHorm Res Paediatr201175533534521228552
  • HertelNTEklöfOIvarssonSGrowth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trialActa Paediatr200594101402141016299871
  • ToumbaMAlbaneseAAzconaCStanhopeREffect of long-term growth hormone treatment on final height of children with Russell-Silver syndromeHorm Res Paediatr201074321221720424422
  • SaggeseGBaroncelliGIBarsantiSGrowth hormone treatment of familial hypophosphatemic ricketsArch Pediatr19985Suppl 4360S363S9853084
  • SaggeseGBaroncelliGIBartelloneSPerriGLong-term growth hormone treatment in children with renal hypophosphatemic rickets: Effect on growth mineral metabolism, and bone densityJ Pediatr199512733954027658269
  • ReuszGSMiltényiGStubnyaGX-linked hypophosphatemia: effects of treatment with recombinant human growth hormonePediatr Nephrol19971155735779323282
  • WilsonDMGrowth hormone and hypophosphatemic ricketsJ Pediatr Endocrinol Metab200013Suppl 299399811086653
  • BaroncelliGIBertelloniSCeccarelliCSaggeseGEffect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic ricketsJ Pediatr2001138223624311174622
  • HuimingYChaominWRecombinant growth hormone therapy for X-linked hypophosphatemia in childrenCochrane Database Syst Rev20051251CD00444715674949
  • RossJLSandbergDERoseSRPsychological adaptation in children with idiopathic short stature treated with growth hormone or placeboJ Clin Endocrinol Metab200489104873487815472178
  • GordonMCrouthamelCPostEMRichmanRAPsychological aspects of constitutional short stature: social competence, behavior problems, self-esteem, and family functioningJ Pediatr198210134774807108676
  • SiegalPTClopperRRStablerBPsychological impact of significantly short statureActa Paediatr Scand Suppl199137714181785309
  • StablerBClopperRRSiegalPTStoppaniCComptonPGUnderwoodLEAcademic achievement and psychological adjustment in short children: the national cooperative growth studyJ Dev Behav Pediatr1994151168195431
  • SteinhausenHCDorrHGKannenbergRMalinZThe behavior profile of children and adolescents with short statureJ Dev Behav Pediatr200021642342811132793
  • DownieABMulliganJStratfordRJBettsPRVossLDAre short normal children at a disadvantage? The Wessex growth studyBMJ19973147074971009006466
  • SkuseDGilmourJTianCSHindmarshPCPsychological assessment of children with short stature: a preliminary reportActa Paediatr Suppl199440611167734805
  • VossLDShort normal stature and psychological disadvantage: a critical review of the evidenceJ Pediatr Endocrinol Metab200114670171111453518
  • VossLDBaileyBJMulliganJWilkinTJBettsPRShort stature and school performance – the Wessex growth studyActa Paediatr Scand Suppl199137729311785313
  • KranzlerJHRosenbloomALProctorBDiamondFBIs short stature a handicap? A comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal statureJ Pediatr200013619610210636982
  • StablerBGrowth hormone insufficiency during childhood has implications for later lifeActa Paediatr Scand Suppl19913779131785319
  • UnderwoodLEThe social cost of being short: societal perceptions and biasesActa Paediatr Scand Suppl1991377381785314
  • SandbergDEBukowskiWMFungCMNollRBHeight and social adjustment: are extremes a cause for concern and action?Pediatrics2004114374475015342848
  • Visser-van BalenHSinnemaGGeenenRGrowing up with idiopathic short stature: psychosocial development and hormone treatment: a critical reviewArch Dis Child200691543343916632673
  • KempSFHeight and social adjustmentPediatrics2005115251551615687470
  • CohenPRogolADDealCLConsensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology workshopJ Clin Endocrinol Metab200893114210421718782877
  • CosgroveCCohenSNormal at Any Cost: Tall Girls, Short Boys, and the Medical Industry’s Quest to Manipulate HeightNew York, NYPenguin Group2009
  • BruttALSandbergDEChaplinJAssessment of health-related quality of life and patient satisfaction in children and adolescents with growth hormone deficiency or idiopathic short stature – Part 1: a critical evaluation of available toolsHorm Res2009722657319690423
  • BullingerMKoltowska-HaggstromMSandbergDEHealth-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature-Part 2: available results and future directionsHorm Res2009722748119690424
  • ChaplinJEKriströmBJonssonBImprovements in behaviour and self-esteem following growth hormone treatment in short prepubertal childrenHorm Res Paediatr201175429130321304250
  • LeeJMDavisMMClarkSJHoferTPKemperAREstimated cost-effectiveness of growth hormone therapy for idiopathic short statureArch Pediatr Adolesc Med2006160326326916520445
  • SavageMOShould idiopathic short stature be treated with growth hormone?Nat Clin Pract Endocrinol Metab20095314814919229234
  • FrindikJPKempSFManaging idiopathic short stature: role of somatropin (rDNA origin) for injectionBiologics2010414715520631818
  • HardinDSEllisKDysonMMcConnelRRiceJSeilheimerDKGrowth hormone improves clinical status in children with cystic fibrosis: results of a randomized controlled trialJ Pediatr2001139563664211713439
  • HardinDSRiceJAhnCGrowth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutritionJ Pediatr2005146332432815756212
  • RuokonenETakalaJDangers of growth hormone therapy in critically ill patientsCurr Opin Clin Nutr Metab Care20025219920911844988
  • TakalaJRuokonenEWebsterNRIncreased mortality associated with growth hormone treatment in critically ill adultsN Engl J Med19993411178579210477776
  • HerndonDNBarrowREKunkelKRBroemelingLRutanRLEffects of recombinant human growth hormone on donor-site healing in severely burned childrenAnn Surg199021244244292121109
  • LalSOWolfSEHerndonDNGrowth hormone, burns and tissue healingGrowth Horm IGF Res2000SupplB 10S394310984252
  • CummingsDEMerriamGRGrowth hormone therapy in adultsAnnu Rev Med20035451353312471175
  • LanfrancoFGianottiLGiordanoRPellegrinoMMaccarioMArvatEAgeing, growth hormone and physical performanceJ Endocrinol Invest200326986187214964439
  • SattlerFRBhasinSHeJDurability of the effects of testosterone and growth hormone supplementation in older community dwelling men: The HORMA trialClin Endocrinol (Oxf) Mar 4201110.1111/j.1365–2265.201104014.x
  • SavineRSönksenPHIs the somatopause an indication for growth hormone replacement?J Endocrinol Invest199922Suppl 514214910442584
  • BirznieceVNelsonAEHoKKYGrowth hormone and physical performanceTrends Endocrinol Metab201122517117821420315
  • YarasheskiKECampbellJASmithKRennieMJHolloszyJOBierDMEffect of growth hormone and resistance exercise on muscle growth in young menAm J Physiol19922623 Pt 1E2612671550219
  • YarasheskiKEZachweijaJJAngelopoulosTJBierDMShort-term growth hormone treatment does not increase muscle protein synthesis in experienced weight liftersJ Appl Physiol1993746307330768366011
  • KrysiakRGdula-DymekABednarska-CzerwińskaAOkopieńBGrowth hormone therapy in children and adultsPharmacol Rep200759550051618048950
  • FestenDAvan ToorenenbergenADuivenvoordenHJHokken-KoelegaACAdiponectin level in prepubertal children with Prader-Willi syndrome before and after growth hormone therapyJ Clin Endocrinol Metab20079241549155417264186
  • RootAWRootMJClinical pharmacology of human growth hormone and its secretagoguesCurr Drug Targets Immune Endocr Metabol Disord200221275212477295
  • QuigleyCAGillAMCroweBJSafety of growth hormone treatment in pediatric patients with idiopathic short statureJ Clin Endocrinol Metab20059095188519615899952
  • LeschekEWRoseSRYanovskiJAEffect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trialJ Clin Endocrinol Metab20048973140314815240584
  • WitJMRekers-MombargLTMCutlerGBJrGrowth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effectJ Pediatr20051461455315644821
  • RenehanAGBrennanBMAcromegaly, growth hormone and cancer riskBest Pract Res Clin Endocrinol Metab200822463965718971124
  • GunnellDOkashaMSmithGDOliverSESandjuJHollyJMHeight, leg length, and cancer risk: a systematic reviewEpidemiol Rev200823231334212192740
  • RowlandsMAGunnellDHarrisRJVLHollyJMMartinRMCirculating insulin-like growth factor peptides and prostate cancer risk: a systematic review adn meta-analysisInt J Cancer2009124102416242919142965
  • PeyratJPBonneterreJHecquetBPlasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancerEur J Cancer199329A44924978435198
  • SwerdlowAJHigginsCDAdlardPPreeceMARisk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85 a cohort studyLancet2002360932927327712147369
  • CarelJCButlerGSafety of recombinant human growth hormoneEndocr Dev201018405420523016
  • Guevara-AguirreJBalasubramanianPGuevara-AguirreMGrowth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humansSci Transl Med201137070ra13